JP2016502995A5 - - Google Patents

Download PDF

Info

Publication number
JP2016502995A5
JP2016502995A5 JP2015547071A JP2015547071A JP2016502995A5 JP 2016502995 A5 JP2016502995 A5 JP 2016502995A5 JP 2015547071 A JP2015547071 A JP 2015547071A JP 2015547071 A JP2015547071 A JP 2015547071A JP 2016502995 A5 JP2016502995 A5 JP 2016502995A5
Authority
JP
Japan
Prior art keywords
vaccine composition
vaccine
intranasal
composition according
glycerol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2015547071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016502995A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/076905 external-priority patent/WO2014095866A1/en
Publication of JP2016502995A publication Critical patent/JP2016502995A/ja
Publication of JP2016502995A5 publication Critical patent/JP2016502995A5/ja
Ceased legal-status Critical Current

Links

JP2015547071A 2012-12-17 2013-12-17 鼻腔内予防接種投薬レジメン Ceased JP2016502995A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201270788 2012-12-17
DKPA201270788 2012-12-17
PCT/EP2013/076905 WO2014095866A1 (en) 2012-12-17 2013-12-17 Intranasal vaccination dosage regimen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018135426A Division JP2018172434A (ja) 2012-12-17 2018-07-19 鼻腔内予防接種投薬レジメン

Publications (2)

Publication Number Publication Date
JP2016502995A JP2016502995A (ja) 2016-02-01
JP2016502995A5 true JP2016502995A5 (enExample) 2016-12-01

Family

ID=49880734

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015547071A Ceased JP2016502995A (ja) 2012-12-17 2013-12-17 鼻腔内予防接種投薬レジメン
JP2018135426A Pending JP2018172434A (ja) 2012-12-17 2018-07-19 鼻腔内予防接種投薬レジメン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018135426A Pending JP2018172434A (ja) 2012-12-17 2018-07-19 鼻腔内予防接種投薬レジメン

Country Status (7)

Country Link
US (1) US9700614B2 (enExample)
EP (1) EP2931309A1 (enExample)
JP (2) JP2016502995A (enExample)
AU (1) AU2013361781B2 (enExample)
HK (1) HK1215546A1 (enExample)
PH (1) PH12015501459A1 (enExample)
WO (1) WO2014095866A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101858840B1 (ko) * 2016-01-15 2018-05-16 단국대학교 천안캠퍼스 산학협력단 집먼지진드기 유래 알레르겐에 의한 과민반응 면역조절제
KR20210141623A (ko) * 2019-03-20 2021-11-23 어드바젠 바이오파르마 컴퍼니 리미티드 점막 면역원성의 조절 방법
WO2024030938A1 (en) * 2022-08-02 2024-02-08 Yale University Compositions, kits, and methods of immunizing against viral infections

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200103018T2 (tr) * 1999-04-19 2002-02-21 Beecham Biologicals S.A. Smithkline İmmünostimülatör oligonükleotid ve saponin içeren katkı bileşikleri.
US20030072764A1 (en) * 2001-04-05 2003-04-17 O'hagan Derek Mucosal boosting following parenteral priming
AU2006247188A1 (en) 2005-05-18 2006-11-23 Children's Hospital & Research Center At Oakland Methods and compositions for immunizing against chlamydia infection
WO2007052057A2 (en) * 2005-11-04 2007-05-10 Novartis Vaccines And Diagnostics Srl Adminstration routes for priming/boosting with influenza vaccines
US8535683B2 (en) 2006-03-22 2013-09-17 Abbott Biologicals B.V. Intranasal or inhalational administration of virosomes
EP1998814A4 (en) 2006-05-11 2010-06-16 Novavax Inc NEW VACCINES AGAINST INFLUENZA M2
GB0905570D0 (en) 2009-03-31 2009-05-13 Novartis Ag Combined vaccines
US8658180B2 (en) 2008-08-15 2014-02-25 Mark A. Miller Vaccines against influenza virus
US20120093859A1 (en) 2009-02-10 2012-04-19 Novartis Ag Influenza vaccine regimens for pandemic-associated strains
WO2012024283A2 (en) 2010-08-16 2012-02-23 The Wistar Institute Of Anatomy And Biology Universal influenza a vaccines
EP2621524A1 (en) 2010-09-30 2013-08-07 Eurocine Vaccines AB Improved vaccine compositions

Similar Documents

Publication Publication Date Title
WO2013006842A3 (en) Self-replicating rna prime - protein boost vaccines
WO2013143683A8 (en) Rna formulation for immunotherapy
EP4056198A3 (en) Outer membrane vesicles
MX2020011717A (es) Composiciones de vacuna que tienen estabilidad e inmunogenicidad mejoradas.
WO2013177214A3 (en) Epitope focusing by variable effective antigen surface concentration
JP2009173664A5 (enExample)
CR20160018A (es) Nueva inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido el carcinoma de pulmón amicrocítico (nsclc)
MX392812B (es) Lipidos cationicos de trialquilo y metodos de uso de los mismos.
EA201591287A1 (ru) Вакцины, содержащие стабилизированные тримеры оболочки вируса иммунодефицита человека, и способы их применения
WO2014018858A3 (en) Multimeric fusion protein vaccine and immunotherapeutic
MX2023006203A (es) Vacunas novedosas contra el virus de zika.
PE20140845A1 (es) Formulaciones parenterales de vacunas contra los norovirus
BR112016008576A2 (pt) Formulações aquosas estáveis de anticorpos e forma farmacêutica de dosagem unitária
PH12018502403A1 (en) Hiv vaccine formulation
EP2897640A4 (en) HEPATITIS B VIRUS CORE PROTEIN AND SURFACE ANTIBODY PROTEIN AND VACCINE THEREWITH
WO2014205199A3 (en) Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
FI3656395T3 (fi) Menetelmiä ja koostumuksia suojaavan immuniteetin aikaansaamiseksi filovirusinfektiota vastaan
PH12015501716B1 (en) Anti-mycoplasma spp. subunit vaccine
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
WO2015140172A3 (en) A medicament for use in a method of inducing or extending a cellular cytotoxic immune response
RU2019110980A (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
RU2016116988A (ru) Вакцина против haemophilus parasuis серологического типа 4
HK1211980A1 (en) Multifunctional oral vaccine based on chromosome recombineering
JP2016502995A5 (enExample)
EP2762153A3 (en) Vaccine composition for mucosal administration